1Cutlip DE. Stent thrombosis:historical perspectives and current Trends[J]. Thromb Thrombolysis, 2000,10 ( 1 ): 89-101.
2Kuchulakanti PK,Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with Sirolimus and paclitaxel-eluting stents [J]. Circulation, 2006,113(8): 1108-1113.
4Orford JL,Lennon R,Melby S,et al. Frequency and correlates of coronary stent thrombosis in the modern era:analysis of a single center registry[J]. Am Coll Cardiol,2002,40(9) :1567-1572.
5Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stentsin humans:delayed healing and late thrombotic risk[J]. Am Coil Cardiol, 2006,48 ( 1 ):193-202.
2Cutlip DE. Stent thrombosis: historical perspectives and current trends. J Thromb Thrombolysis, 2000, 10:89-101.
3Honda Y, Fitzgerald PJ. Stent thrombosis: an issue revisited in a changing world. Circulation, 2003, 108 : 2-5.
4Ischinger TA. Antithrombotics in interventional cardiology:optimizing treatment and strategies. Am J Cardiol, 1998, 82 : 25L-28L.
5Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation, 2006, 113:1108-1113.
6Farb A, Burke AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation, 2003,108:1701-1706.
7Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation, 2003, 108 : 4347.
8Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation, 2004,109 : 1930-1932.
9La Vecchia L, Bedogni F, Vincenzi M. Subacute stent thrombosis occurring more than one month after implantation for acute myocardial infarction. Description of two cases successfully treated with angioplasty and further stenting. Cardiology, 1998, 90:305-308.
3CUTLIP D E,WINDECKER S,MEHRAN R,et al.Clinical end points in coronary stem trails:a case for standardized definitions[J].Circulation,2007,115(17):2344-2351.
4PARK D W,PARK S W,PARK K H,et al.Frequency of and risk factors of stent thrombosis after drug-eluting stent implantation during long-term follow-up[J].Am J Cardiol,2006,98(3):352-356.
5BUONAMICI P,MARCUCCI R,MIGLIORINI A,et al.Impact of platelet reactivity after clopidogrel administration on drugeluting stent thrombosis[J].J Am Coll Cardiol,2007,49(24):2312-2317.
6DE LA TORRE-HERN(A)NDEZ J M,ALFONSO F,HERN(A)NDEZ F,et al.drug-eluting stent thrombosis results from the multicenter Spanish registry ESTROFA(estudio esspanol sobre trombosis de stents farmacoactivos)[J].J Am Coll Cardiol,2008,51(10):986-990.
7BURZOTTA F,PARMA A,PRISTIPINO C,et al.Angiographic and clinical outcome of invasively managed patients with thrombosed coronarybare metal Or drug-eluting stent:the OPTIMIST study[J].European Heart Journal,2008,29(24):3011-3021.
8KUCHULAKANTI P K,CHU W W,TORGUSON R,et al.Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents[J].Circulation,2006,113(8):1108-1113.
9Palmerini T, Barozzi C, Tomasi L, et al. A randomised study comparing the antiplatelet and antiinflammatory effect of clopi- dogrel 150 rag/day versus 75 rag/day in patients with ST-seg- ment elevation acute myocardial infarction and poor responsive- ness to clopidogrel: results from the DOUBLE study[J]. Thromb Res, 2010,125 (4) : 309-314.
10Nguyen TA, Lordkipanidz M, Diodati JG, et al. Week long high-maintenance dose elopidogrel regimen achieves better platelet aggregation inhibition than a standard loading dose before percutaneous coronary intervention: results of a double- blind, randomized clinical trial [J]. J Interv Cardiol, 2009, 22 (4) :368-377.
